After-Hours Movers 12/20: (FSII) (CTAS) (RIMM) Higher; (ORCL) (JBL) (PAYX) Lower
Oracle Corp (NASDAQ: ORCL) 9.9% LOWER; reported Q2 EPS of $0.54, $0.03 worse than the analyst estimate of $0.57. Revenue for the quarter came in at $8.8 billion versus the consensus estimate of $9.23 billion. Authorized added $5 billion buyback. Sees Q3 sales up 1-5% in US dollars, or 3-7% in constant currency. Sees Q3 adj-EPS of 55-58c in US dollars, 56-59c constant currency.
FSI International, Inc. (NASDAQ: FSII) 8% HIGHER; reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $17.76 million. Sees Q2 2012 revenue of $30-$35 million.
Cintas Corp (NASDAQ: CTAS) 7.2% HIGHER; reported Q2 EPS of $0.57, $0.09 better than the analyst estimate of $0.48. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1 billion. Cintas Corp sees FY2012 EPS of $2.16-$2.20, versus prior guidance of $1.97-$2.05 and the consensus of $2.03. Cintas Corp sees FY2012 revenue of $4.075-$4.125 billion, versus prior guidance of $4.0-$4.1 billion and the consensus of $4.08 billion.
Research In Motion (Nasdaq: RIMM) 7% HIGHER; hearing Reuters reports the company turned down takeover offers from Amazon.com (Nasdaq: AMZN) and others. Click here to see the full report.
Ampio Pharma (Nasdaq: AMPE) 6% LOWER; filed a prospectus for an offering of common stock.
Jabil Circuit, Inc. (NYSE: JBL) 4.2% LOWER; reported Q1 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $4.33 billion versus the consensus estimate of $4.41 billion. Jabil Circuit, Inc. sees Q2 2012 EPS of $0.52-$0.62, versus the consensus of $0.60.
Nanosphere, Inc. (Nasdaq: NSPH) 4% HIGHER; has obtained CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on the automated sample-to-result Verigene System.
Paychex, Inc. (NASDAQ: PAYX) 3.6% LOWER; reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $545.7 million versus the consensus estimate of $551.66 million.
Nike Inc. (NYSE: NKE) 2.9% HIGHER; reported Q2 EPS of $1.00, $0.03 better than the analyst estimate of $0.97. Revenue for the quarter came in at $5.73 billion versus the consensus estimate of $5.63 billion. Futures orders up 13 percent to $8.9 billion. Inventories up 35 percent.
Valmont (NYSE: VMI) 2.6% HIGHER; sees FY11 adj-EPS modestly above the high end of its previously-issued $5.70-$5.90 guidance range. Click here to see the full report.
OpenTable (Nasdaq: OPEN) INDICATED LOWER; announced its Chairman Jeff Jordan resigned. The company has named Thomas Layton as the interim Chairman.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
FSI International, Inc. (NASDAQ: FSII) 8% HIGHER; reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $17.76 million. Sees Q2 2012 revenue of $30-$35 million.
Cintas Corp (NASDAQ: CTAS) 7.2% HIGHER; reported Q2 EPS of $0.57, $0.09 better than the analyst estimate of $0.48. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1 billion. Cintas Corp sees FY2012 EPS of $2.16-$2.20, versus prior guidance of $1.97-$2.05 and the consensus of $2.03. Cintas Corp sees FY2012 revenue of $4.075-$4.125 billion, versus prior guidance of $4.0-$4.1 billion and the consensus of $4.08 billion.
Research In Motion (Nasdaq: RIMM) 7% HIGHER; hearing Reuters reports the company turned down takeover offers from Amazon.com (Nasdaq: AMZN) and others. Click here to see the full report.
Ampio Pharma (Nasdaq: AMPE) 6% LOWER; filed a prospectus for an offering of common stock.
Jabil Circuit, Inc. (NYSE: JBL) 4.2% LOWER; reported Q1 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $4.33 billion versus the consensus estimate of $4.41 billion. Jabil Circuit, Inc. sees Q2 2012 EPS of $0.52-$0.62, versus the consensus of $0.60.
Nanosphere, Inc. (Nasdaq: NSPH) 4% HIGHER; has obtained CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on the automated sample-to-result Verigene System.
Paychex, Inc. (NASDAQ: PAYX) 3.6% LOWER; reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $545.7 million versus the consensus estimate of $551.66 million.
Nike Inc. (NYSE: NKE) 2.9% HIGHER; reported Q2 EPS of $1.00, $0.03 better than the analyst estimate of $0.97. Revenue for the quarter came in at $5.73 billion versus the consensus estimate of $5.63 billion. Futures orders up 13 percent to $8.9 billion. Inventories up 35 percent.
Valmont (NYSE: VMI) 2.6% HIGHER; sees FY11 adj-EPS modestly above the high end of its previously-issued $5.70-$5.90 guidance range. Click here to see the full report.
OpenTable (Nasdaq: OPEN) INDICATED LOWER; announced its Chairman Jeff Jordan resigned. The company has named Thomas Layton as the interim Chairman.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
- UPDATE: Global Hunter Securities Starts Kosmos Energy (KOS) at Buy; High Risk, High Reward
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours Movers, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
